Aptevo Therapeutics Files S-1/A Amendment
Ticker: APVO · Form: S-1/A · Filed: Apr 1, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | S-1/A |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration, amendment
Related Tickers: APVO
TL;DR
APVO filed an S-1/A amendment, looks like they're prepping for more stock.
AI Summary
Aptevo Therapeutics Inc. filed an S-1/A amendment on April 1, 2025, for its registration statement. The company, incorporated in Delaware with its principal executive offices in Seattle, WA, is in the pharmaceutical preparations industry. This filing is an amendment to a previous registration statement, indicating ongoing efforts to register securities.
Why It Matters
This S-1/A filing signifies that Aptevo Therapeutics is actively working on registering securities, which could involve future stock offerings or other capital-raising activities.
Risk Assessment
Risk Level: medium — S-1/A filings often precede stock offerings, which can dilute existing shareholders or indicate the company needs capital, carrying inherent risks.
Key Numbers
- 333-285476 — SEC File Number (Identifies the specific registration statement being amended.)
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- 20250401 (date) — Filing Date
- 333-285476 (registration_number) — SEC File Number
- 2401 4th Avenue, Suite 1050 Seattle, Washington, 98121 (address) — Principal Executive Offices
- 206-838-0500 (phone_number) — Business Phone
- Marvin L. White (person) — President and Chief Executive Officer
FAQ
What is the purpose of this S-1/A filing?
This is an amendment (Amendment No. 4) to a Form S-1 Registration Statement, indicating ongoing efforts to register securities with the SEC.
When was this amendment filed?
The filing was made on April 1, 2025.
What is Aptevo Therapeutics Inc.'s principal business address?
The principal executive offices are located at 2401 4th Avenue, Suite 1050, Seattle, Washington, 98121.
Who is the President and CEO of Aptevo Therapeutics Inc.?
Marvin L. White is the President and Chief Executive Officer.
What is the company's state of incorporation?
Aptevo Therapeutics Inc. is incorporated in Delaware.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on April 1, 2025 by Marvin L. White regarding Aptevo Therapeutics Inc. (APVO).